Abiomed Inc (NASDAQ:ABMD)

178.67
Delayed Data
As of Oct 16
 +0.80 / +0.45%
Today’s Change
155.02
Today|||52-Week Range
427.70
-45.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line50.1M44.9M74.0M88.9M
 
 
 
 
 
Depreciation3.4M3.6M4.2M4.4M
 
 
 
 
 
Total Other Cash Flow16.7M16.4M-20.3M-25.2M
 
 
 
 
 
Funds From Operations69.0M84.5M76.1M78.8M
 
 
 
 
 
Funds From/For Other Operating Expenses8.5M9.9M5.7M14.2M
 
 
 
 
 
Net Cash Flow - Operating Activities60.6M74.6M70.4M64.6M
 
 
 
 
 
 
InvestingIncrease In Investments-87.1M-128.8M-162.6M-124.1M
 
 
 
 
 
Decrease In Investments61.1M90.1M104.9M93.2M
 
 
 
 
 
Capital Expenditures-23.6M-27.1M21.9M-15.1M
 
 
 
 
 
Net Cash Flow Investing-49.7M-65.8M-35.8M-45.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale4.1M-1.1M3.0M-39.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing4.1M-1.1M3.0M-39.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash62.0K118.0K-816.0K612.0K
 
 
 
 
 
 
Net Change In Cash15.0M7.7M37.7M-20.6M